- Home
- VABK vs AARD Comparison
VABK vs AARD Comparison
Compare VABK & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VABK
- AARD
- Stock Information
- Founded
- VABK 1998
- AARD 2017
- Country
- VABK United States
- AARD United States
- Employees
- VABK N/A
- AARD N/A
- Industry
- VABK Major Banks
- AARD Biotechnology: Pharmaceutical Preparations
- Sector
- VABK Finance
- AARD Health Care
- Exchange
- VABK Nasdaq
- AARD Nasdaq
- Market Cap
- VABK 206.0M
- AARD 154.9M
- IPO Year
- VABK N/A
- AARD 2025
- Fundamental
- Price
- VABK $36.74
- AARD $10.73
- Analyst Decision
- VABK
- AARD Strong Buy
- Analyst Count
- VABK 0
- AARD 4
- Target Price
- VABK N/A
- AARD $31.50
- AVG Volume (30 Days)
- VABK 5.0K
- AARD 62.2K
- Earning Date
- VABK 04-24-2025
- AARD 01-01-0001
- Dividend Yield
- VABK 3.84%
- AARD N/A
- EPS Growth
- VABK 3.77
- AARD N/A
- EPS
- VABK 3.30
- AARD N/A
- Revenue
- VABK $55,119,000.00
- AARD N/A
- Revenue This Year
- VABK N/A
- AARD N/A
- Revenue Next Year
- VABK N/A
- AARD N/A
- P/E Ratio
- VABK $11.15
- AARD N/A
- Revenue Growth
- VABK 1.78
- AARD N/A
- 52 Week Low
- VABK $28.71
- AARD $4.88
- 52 Week High
- VABK $44.00
- AARD $19.58
- Technical
- Relative Strength Index (RSI)
- VABK 55.53
- AARD N/A
- Support Level
- VABK $35.91
- AARD N/A
- Resistance Level
- VABK $37.51
- AARD N/A
- Average True Range (ATR)
- VABK 0.84
- AARD 0.00
- MACD
- VABK 0.19
- AARD 0.00
- Stochastic Oscillator
- VABK 73.47
- AARD 0.00
About VABK Virginia National Bankshares Corporation
Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses and charitable organizations.
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.